90 related articles for article (PubMed ID: 29879960)
1. Significance of serum ferritin as a prognostic factor in advanced hepatobiliary cancer patients treated with Korean medicine: a retrospective cohort study.
Song A; Eo W; Kim S; Shim B; Lee S
BMC Complement Altern Med; 2018 Jun; 18(1):176. PubMed ID: 29879960
[TBL] [Abstract][Full Text] [Related]
2. The crucial value of serum ferritin in assessing high-risk factors and prognosis for patients with endometrial carcinoma.
Liu J; Xuan B; Quan Q; Gong S; Mu X
BMC Womens Health; 2023 Aug; 23(1):415. PubMed ID: 37550644
[TBL] [Abstract][Full Text] [Related]
3. Can serum ferritin serve as a biomarker for the prognosis of gynecological malignant tumors? A retrospective cohort study.
Zhang W; Chen Q; Cheng Y; Wang M; Tong J; Tang R; Pan Y; Yang J
Cancer Biomark; 2024; 39(2):127-136. PubMed ID: 38160345
[TBL] [Abstract][Full Text] [Related]
4. Association of preoperative elevated lipoprotein (a) with poor survival in patients with biliary tract cancers.
Fan S; Mao Y; Ge Y; Liang Z
Cancer Med; 2024 Jun; 13(11):e7331. PubMed ID: 38819582
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Host-related Biomarkers for Survival in Patients with Advanced Non-Small Cell Lung Cancer.
Lee S; Eo W; Jeon H; Park S; Chae J
J Cancer; 2017; 8(15):2974-2983. PubMed ID: 28928889
[TBL] [Abstract][Full Text] [Related]
6. Malignancy-related ascites in palliative care units: prognostic factor analysis.
Kadono T; Ishiki H; Yokomichi N; Ito T; Maeda I; Hatano Y; Miura T; Hamano J; Yamaguchi T; Ishikawa A; Suzuki Y; Arakawa S; Amano K; Satomi E; Mori M
BMJ Support Palliat Care; 2024 Jan; 13(e3):e1292-e1299. PubMed ID: 37080735
[TBL] [Abstract][Full Text] [Related]
7. Clinical, biochemical and pulmonary CT imaging features for hepatobiliary involvement in COVID-19.
Dumea E; Barbu EC; Chiţu CE; Lazăr M; Ion DA
Germs; 2023 Jun; 13(2):121-129. PubMed ID: 38144251
[TBL] [Abstract][Full Text] [Related]
8. Ferritin as prognostic marker in COVID-19: the FerVid study.
Para O; Caruso L; Pestelli G; Tangianu F; Carrara D; Maddaluni L; Tamburello A; Castelnovo L; Fedi G; Guidi S; Pestelli C; Pennella B; Ciarambino T; Nozzoli C; Dentali F
Postgrad Med; 2022 Jan; 134(1):58-63. PubMed ID: 34613875
[TBL] [Abstract][Full Text] [Related]
9. [Hyperferritinemia in a Chilean Academic Healthcare Network: A Retrospective Study].
Huenur F J; Parodi C M; Aravena G C; Eymin L G; Triantafilo C N; Walkowiak N S; Valenzuela S A; Corsi S Ó
Rev Med Chil; 2023 Apr; 151(4):412-419. PubMed ID: 38687515
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Investigations of Multiple Factors That Are Related to Refractory Outcome in Urosepsis Patients.
Sejima T; Masago T; Morizane S; Honda M; Takenaka A
Yonago Acta Med; 2022 Aug; 65(3):254-261. PubMed ID: 36061583
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for hepatobiliary cancers: treatment strategies in the East and West.
Midorikawa Y
Hepatobiliary Surg Nutr; 2023 Aug; 12(4):580-584. PubMed ID: 37600978
[No Abstract] [Full Text] [Related]
12. The upward trend in the immunotherapy utilization for hepatobiliary cancers.
Lan XB; Papatheodoridis G; Teng YX; Zhong JH
Hepatobiliary Surg Nutr; 2021 Oct; 10(5):692-695. PubMed ID: 34760976
[No Abstract] [Full Text] [Related]
13. Implication of Ferroptosis in Cholangiocarcinoma: A Potential Future Target?
Yang M; Li M; Lyu Z; Yang Z
Cancer Manag Res; 2023; 15():335-342. PubMed ID: 37063167
[TBL] [Abstract][Full Text] [Related]
14. Differential Diagnosis of Hyperferritinemia in Critically Ill Patients.
Schuster FS; Nyvlt P; Heeren P; Spies C; Adam MF; Schenk T; Brunkhorst FM; Janka G; La Rosée P; Lachmann C; Lachmann G
J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36614993
[TBL] [Abstract][Full Text] [Related]
15. Role of Fe, Transferrin and Transferrin Receptor in Anti-Tumor Effect of Vitamin C.
Qiu J; Wu R; Long Y; Peng L; Yang T; Zhang B; Shi X; Liu J; Zhang X
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139668
[TBL] [Abstract][Full Text] [Related]
16. 1,8 Cineole and Ellagic acid inhibit hepatocarcinogenesis via upregulation of MiR-122 and suppression of TGF-β1, FSCN1, Vimentin, VEGF, and MMP-9.
Abdallah HMI; El Awdan SA; Abdel-Rahman RF; Farrag ARH; Allam RM
PLoS One; 2022; 17(1):e0258998. PubMed ID: 35081125
[TBL] [Abstract][Full Text] [Related]
17. A Nomogram Based on Circulating CD4
Shen DS; Yan C; Chen KH; Li L; Qu S; Zhu XD
J Inflamm Res; 2021; 14():6707-6718. PubMed ID: 34916820
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 Is a Potential Modulator for Orchestrating Iron Homeostasis and Redox Balance in Cancer Cells.
Zhang L; Zhang J; Jin Y; Yao G; Zhao H; Qiao P; Wu S
Front Cell Dev Biol; 2021; 9():728172. PubMed ID: 34589492
[TBL] [Abstract][Full Text] [Related]
19. Iron regulatory protein 1 promotes ferroptosis by sustaining cellular iron homeostasis in melanoma.
Yao F; Cui X; Zhang Y; Bei Z; Wang H; Zhao D; Wang H; Yang Y
Oncol Lett; 2021 Sep; 22(3):657. PubMed ID: 34386079
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of the prognostic value of pretreatment serum ferritin in hepatobiliary and pancreas (HBP) cancers.
Lin S; Fang Y; Lin Y; Mo Z; Hong X; Jian Z; Ji C
BMJ Open; 2021 May; 11(5):e040801. PubMed ID: 34049899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
